Skip to main content
Premium Trial:

Request an Annual Quote

Stephen Oldfield, Gustavo Salem, Beckman Coulter, Acolyte Biomedica

Premium

Migrations

ForteBio recently named Stephen Oldfield to the new position of vice president of marketing and sales.

Oldfield joined ForteBio in early August from Molecular Devices, where he was vice president of worldwide marketing. He will be responsible for recruiting marketing and sales personnel in support of ForteBio's first product launch later this year, ForteBio said. Prior to his employment with Molecular Devices, Oldfield held senior marketing positions at Molecular Probes, FMC BioProducts, Molecular Dynamics, and Pharmacia Biotechnology AB. Oldfield received a PhD in pure and applied biology from the Imperial College, London, and a BS in genetics from the University of Sheffield in the UK.


Assay Designs has appointed Gustavo Salem as its new president and CEO, the Ann Arbor, Mich.-based biotech firm said last week.

Prior to joining Assay Designs, Salem held a variety of positions at Bio-Rad Laboratories, including division manager of protein separations and business unit manager for biomaterials. Prior to this, he held a series of sales and marketing positions at PerSeptive Biosystems, Beckman Instruments, and Amersham.

 

Products

Beckman Coulter last week introduced the IOTest Anti-Cyclin A2 monoclonal antibody for the study of cell-cycle transitions in life science research.

The FITC-conjugated antibody is the newest addition to Beckman's universal cytometry reagent line, which works on all instrument platforms, including the company's Cell Lab Quanta and FC 500 MPL flow cytometers, Beckman said. The new antibody is useful in a wide range of applications such as basic research on cell cycle control; apoptosis and tumorigenesis; clinical cancer studies; and pharmaceutical discovery to identify inhibitors, blockers, and anti-mitotic drugs, Beckman said.


Acolyte Biomedica has expanded its BacLite RapiTECT kits to include a mammalian cell enumeration assay, the UK-based company said last week.

The BacLite RapiTECT M uses the Acolyte Biomedica AK Rapid technology, in which adenylate kinase is used as a highly sensitive marker to measure mammalian cells, Acolyte said. The development is being undertaken in collaboration with Barbara Reeves, an cellular and molecular biology professor at the University of Bath.

The Scan

Not Yet a Permanent One

NPR says the lack of a permanent Food and Drug Administration commissioner has "flummoxed" public health officials.

Unfair Targeting

Technology Review writes that a new report says the US has been unfairly targeting Chinese and Chinese-American individuals in economic espionage cases.

Limited Rapid Testing

The New York Times wonders why rapid tests for COVID-19 are not widely available in the US.

Genome Research Papers on IPAFinder, Structural Variant Expression Effects, Single-Cell RNA-Seq Markers

In Genome Research this week: IPAFinder method to detect intronic polyadenylation, influence of structural variants on gene expression, and more.